Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias-Reference-Cited by-同舟云学术

Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias

Published:2006-09 Issue: Volume: Page:1140-1149
ISSN:0147-5185
Container-title:The American Journal of Surgical Pathology
language:en
Short-container-title:The American Journal of Surgical Pathology

Author:

Gill Anthony J.,Clarkson Adele,Gimm Oliver,Keil Juliane,Dralle Henning,Howell Viive M.,Marsh Deborah J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference38 articles.

1. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining*1

2. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases

3. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome

4. Hyperparathyroidism-Jaw Tumor Syndrome in Roma Families from Portugal Is Due to a Founder Mutation of the HRPT2 Gene

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The road ahead: a brief guide to navigating the 2022 WHO classification of endocrine and neuroendocrine tumours;Journal of Clinical Pathology;2024-07-09

2. Painting the path to precision: unraveling endocrine tumors with immunohistochemistry;Diagnostic Histopathology;2024-06

3. Insights into Hyperparathyroidism–Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of CDC73 Gene and Parafibromin-Deficient Tumours;International Journal of Molecular Sciences;2024-02-15

4. Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance;Virchows Archiv;2023-12-18

5. Parathyroid carcinoma in a patient with primary hyperparathyroidism mimicking parathyroid adenoma;BMJ Case Reports;2023-09